D.Western Therapeutics Institute Inc 4576.T-JP:Tokyo Stock Exchange

*Data is delayed | JPY
Last | 03/03/21 JST
296.00UNCH (UNCH)
52 week range
268.00 - 528.00

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close296.00
  • 52 Week High528.00
  • 52 Week High Date06/10/20
  • 52 Week Low268.00
  • 52 Week Low Date12/28/20
  • Market Cap81.11M
  • Shares Out29.25M
  • 10 Day Average Volume86,520
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-27.8

RATIOS/PROFITABILITY

  • EPS (TTM)-18.10
  • P/E (TTM)-16.35
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest D.Western Therapeutics Institute Inc News

There is no recent news for this security.

Latest 4576.T-JP News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
D.Western Therapeutics Institute, Inc. is a Japan-based company engaged in the research and development of new pharmaceuticals. The Company generates revenue from licensing of its developed drugs to other companies. As of December 31, 2012, the Company’s drug pipeline included anti-thrombotic medicine K-134, therapeutic agent K-115 for glaucoma, and anticancer drug HMN-214. Its newly-developed products include new anti-thrombotic medicine and signal-transduction inhibitors...
Hiroyoshi Hidaka
Chairman
Yuichi Hidaka
President
Address
1-18-11, Nishiki
Nagoya-shi, ACH
460-0003
Japan